Pathology of a live attenuated anti-schistosome vaccine in mice.

Authors:
Address:
Journal:


Publication:

abstract

Tissue responses of mice to intramuscular injection of 50 kR 60Co-attenuated schistosomula of Schistosoma mansoni were studied. Controls included injection of unattenuated schistosomula, medium alone, antigen-coated beads, and alum-adsorbed tetanus/diphtheria toxoids. Primary reactions to tissue-confined deposits of injected schistosomula, whether attenuated or not, were relatively intense and prolonged. Parasite attrition proceeded steadily, with most destroyed by the 7th day; however, a few intact organisms persisted up to 4 weeks. Cryopreservation did not alter the course of parasite attrition nor host reaction. Irradiated larvae were not found in lymph nodes, lungs, or liver. Neutrophils dominated the early reactions and were gradually replaced by mononuclear phagocytes, lymphoid cells, and eosinophils. Fibroblast proliferation and muscle regeneration began by day 3; reaction size and intensity peaked by day 7. From weeks 1-4, inflammatory infiltrates and regenerative proliferation underwent gradual involution, and injection sites were healed with no scarring by the end of 4-5 weeks. Mice primed by infection or by prior injection showed an accelerated course of inflammation, enhanced tissue eosinophilia, and more rapid healing. An unwanted, but prominent, feature of schistosomular vaccine reactions in mice was tracking of the inflammatory infiltrate along connective tissue septal and nerve sheaths, the latter raising the question of the pain potential of the vaccine. To conclude, in mice, attenuated schistosomular vaccines cause relatively marked local inflammatory responses but no systemic lesions at all, and their injection sites heal without permanent damage.



Related Articles
Pathology resulting from the administration of a live attenuated anti-Schistosoma haematobium vaccine in baboons.
Am J Trop Med Hyg. 1989
Pathology resulting from the administration of a live attenuated anti-Schistosoma haematobium vaccine in baboons.
Byram JE, Harrison RA, von Lichtenberg F, Webbe G, Sturrock RF. Am J Trop Med Hyg. 1989 Jan; 40(1):55-65.
A lung model of schistosome immunity in mice.
Am J Pathol. 1977
A lung model of schistosome immunity in mice.
von Lichtenberg F, Sher A, McIntyre S. Am J Pathol. 1977 Apr; 87(1):105-23.
The fate of challenge schistosomula in the murine anti-schistosome vaccine model.
Am J Trop Med Hyg. 1985
The fate of challenge schistosomula in the murine anti-schistosome vaccine model.
Von Lichtenberg F, Correa-Oliveira R, Sher A. Am J Trop Med Hyg. 1985 Jan; 34(1):96-106.
Review Immune responses to the radiation-attenuated schistosome vaccine: what can we learn from knock-out mice?
Immunol Lett. 1999
Review Immune responses to the radiation-attenuated schistosome vaccine: what can we learn from knock-out mice?
Wilson RA, Coulson PS, Mountford AP. Immunol Lett. 1999 Jan; 65(1-2):117-23.
Review Genetic engineering and a schistosome vaccine.
Vet Parasitol. 1984
Review Genetic engineering and a schistosome vaccine.
Taylor DW, Cordingley JS, Butterworth AE. Vet Parasitol. 1984 Jun; 14(3-4):285-98.
Macrophage activation as an immune correlate to protective immunity against schistosomiasis in mice immunized with an irradiated, cryopreserved live vaccine.
Infect Immun. 1987
Macrophage activation as an immune correlate to protective immunity against schistosomiasis in mice immunized with an irradiated, cryopreserved live vaccine.
Lewis FA, Winestock J, James SL. Infect Immun. 1987 Jun; 55(6):1339-45.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.